Classical hairy cell leukemia and its variant: A 17-year retrospective survey in taiwan Chinese

Acta Haematologica

Volumn 126, Issue 3, 2011, Pages 186-193

  Kao, Hsiao Wen ^a   Dunn, Po ^a,b   Kuo, Ming Chung ^a   Shih, Lee Yung ^a,b   Lin, Tung Liang ^a   Wu, Jin Hou ^a   Tang, Tzung Chih ^a   Chang, Hung ^a   Wu, Hong Cheng ^c   Hung, Yu Shin ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

Cladribine; Hairy cell leukemia; Radiotherapy; Variant

Indexed keywords

ALPHA INTERFERON; CHLORAMBUCIL; CLADRIBINE; CYCLOPHOSPHAMIDE; PREDNISOLONE;

ABDOMINAL DISCOMFORT; ADULT; AGED; BONE MARROW BIOPSY; CANCER GROWTH; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHINESE; CLASSICAL HAIRY CELL LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FATIGUE; FEMALE; FEVER; HAIRY CELL LEUKEMIA; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LEUKOCYTOSIS; LEUKOPENIA; LIVER BIOPSY; MALE; MEDICAL RECORD REVIEW; MONOCYTOPENIA; MUCOSAL BLEEDING; PHENOTYPE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SPLEEN; SPLENECTOMY; TAIWAN; THROMBOCYTOPENIA; TREATMENT INDICATION; TREATMENT RESPONSE; VARIANT HAIRY CELL LEUKEMIA;

ADULT; AGED; FEMALE; HUMANS; LEUKEMIA, HAIRY CELL; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TAIWAN;

EID: 80051601997     PISSN: 00015792     EISSN: 14219662     Source Type: Journal    
DOI: 10.1159/000328887     Document Type: Review

References (34)

1. Cawley JC, Burns GF, Hayhoe FG: A chronic lymphoproliferative disorder with distinctive features: A distinct variant of hairy cell leukemia. Leuk Res 1980; 4: 547-559. (Pubitemid 11207672)
2. Matutes E, Wotherspoon A, Catovsky D: The variant form of hairy-cell leukaemia. Best Pract Res Clin Haematol 2003; 16: 41-56.
3. Au WY, Kwong YL, Ma SK, Mak YK, Wong KF, Lei KI, Ng MH, Chan JC, Lin SY, Lee KK, Liang R: Hairy cell leukemia in Hong Kong Chinese: A 12-year retrospective survey. Hematol Oncol 2000; 18: 155-159. (Pubitemid 32099370)
4. Yu YB, Li CY, Chen CC, You JY, Chau WK, Hsu HC, Gau JP, Chen PM, Ho CH: Combined treatment with splenectomy and cladribine in hairy cell leukemia in Taiwan: A clinicopathologic study of 5 cases. J Chin Med Assoc 2007; 70: 551-555.
5. Dunn P, Shih LY, Ho YS, Tien HF: Hairy-cell leukemia variant. Acta Haematol 1995; 94: 105-108.
6. Wong KF, Kwong YL, Hui PK: Hairy cell leukemia variant with t(2; 8)(p12;q24) abnormality. Cancer Genet Cytogenet 1997; 98: 102-105. (Pubitemid 27431125)
7. Foucar K, Falini B, Catovsky D, Stein H: Hairy cell leukaemia; Piris M, Foucar K, Mollejo M, Campo E, Falini B: Splenic Bcell lymphoma/leukaemia, unclassifiable; in Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds): WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, IARC, 2008, pp 188-193.
8. Brown BA: Hematology: Principles and Procedures, ed 3. Philadelphia, Lea & Febiger, 1980.
9. Bernstein L, Newton P, Ross RK: Epidemiology of hairy cell leukemia in Los Angeles county. Cancer Res 1990; 50: 3605-3609. (Pubitemid 20194103)
10. Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS: Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 2006; 107: 265-276. (Pubitemid 43053551)
11. Kwong YL, Wong KF, Chan LC, Liang RH, Chan JK, Wei D, Chiu EK, Chan CH, Todd D, Chan TK: The spectrum of chronic lymphoproliferative disorders in Chinese people - an analysis of 64 cases. Cancer 1994; 74: 174-181. (Pubitemid 24187627)
12. Machii T, Tokumine Y, Inoue R, Kitani T: Predominance of a distinct subtype of hairycell leukemia in Japan. Leukemia 1993; 7: 181-186. (Pubitemid 23079224)
13. Kondo H, Takeuchi H, Katayama I: Differentiating atypical HCL from HCL-Japanese variant. Leukemia 1996; 10: 384.
14. Yamaguchi M, Machii T, Shibayama H, Tokumine Y, Hara J, Yutsudo M, Yamada O, Klobeck HG, Kitani T: Immunophenotypic features and configuration of immunoglobulin genes in hairy cell leukemia Japanese variant. Leukemia 1996; 10: 1390-1394. (Pubitemid 26261441)
15. Kitani T, Machii T, Inoue R, Kanakura Y: Hairy cell leukemia: A report of 10 cases in Japan and characterization of anti-hairy cell sera. Jpn J Clin Oncol 1983; 13: 497-509.
16. Matutes E: Immunophenotyping and differential diagnosis of hairy cell leukemia. Hematol Oncol Clin North Am 2006; 20: 1051-1063. (Pubitemid 44380352)
17. Hisada M, Chen BE, Jaffe ES, Travis LB: Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: A population-based study. J Natl Cancer Inst 2007; 99: 215-222.
18. Troussard X, Henry-Amar M, Flandrin G: Second cancer risk after interferon therapy. Blood 1994; 84: 3242-3244. (Pubitemid 24328124)
19. Else M, Dearden CE, Matutes E, Garcia-Talavera J, Rohatiner AZ, Johnson SA, O'Connor NT, Haynes A, Osuji N, Forconi F, Lauria F, Catovsky D: Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis. Br J Haematol 2009;145:733-740.
20. Kampmeier P, Spielberger R, Dickstein J, Mick R, Golomb H, Vardiman JW: Increased incidence of second neoplasms in patients treated with Interferonα 2b for hairy cell leukemia: A cinicopathological assessment. Blood 1994; 83: 2931-2938. (Pubitemid 24142726)
21. Kurzrock R, Strom SS, Estey E, OBrien S, Keating MJ, Jiang H, Adams T, Talpaz M: Second cancer risk in hairy cell leukemia: Analysis of 350 patients. J Clin Oncol 1997; 15: 1803-1810. (Pubitemid 27209507)
22. Ruco LP, Procopio A, Maccallini V, Calogero A, Uccini S, Annino L, Mandelli F, Baroni CD: Severe deficiency of natural killer activity in the peripheral blood of patients with hairy cell leukemia. Blood 1983; 61: 1132-1137. (Pubitemid 13099901)
23. Mackowiak PA, Demian SE, Sutker WL, Murphy FK, Smith JW, Tompsett R, Sheehan WW, Luby JP: Infections of hairy cell leukemia: Clinical evidence of a pronounced defect in cell-mediated immunity. Am J Med 1980; 68: 718-724. (Pubitemid 10096038)
24. Grever MR, Zinzani PL: Long-term followup studies in hairy cell leukemia. Leuk Lymphoma 2009; 50: 23-26.
25. Huynh E, Sigal D, Saven A: Cladribine in the treatment of hairy cell leukemia: Initial and subsequent results. Leuk Lymphoma 2009; 50: 12-17.
26. Sgarabotto D, Vianello F, Radossi P, Poletti A, Sotti G, Stefani PM, Sartori R, Girolami A: Remission in hairy cell leukemia-variant following splenic radiotherapy alone. Leuk Lymphoma 1997; 26: 395-398. (Pubitemid 27401924)
27. Robak T, Blasinska-Morawiec M, Blonski J, Hellmann A, Halaburda K, Konopka L, Kotlarek-Haus S, Potoczek S, Hansz J, Dmoszynska A, Urasinski I, Zdziarska B, Dwilewicz-Trojaczek J, Holowiecki J, Skotnicki AB: 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland. Eur J Haematol 1999; 62: 49-56. (Pubitemid 29029918)
28. Tetreault SA, Robbins BA, Saven A: Treatment of hairy cell leukemia-variant with cladribine. Leuk Lymphoma 1999; 35: 347-354.
29. Palomera L, Domingo JM, Sola C, Azaceta G, Calvo MT, Gutierrez M: Cladribine (2-chlorodeoxyadenosine) therapy in hairy cell leukemia variant. A report of three cases. Haematologica 2002; 87: 107-108. (Pubitemid 34101120)
30. Busemann C, Schüler F, Krüger W, Kiefer T, Wuppermann M, Androshchuk M, Dölken G: Late extramedullary relapse after allogeneic transplantation in a case of variant hairy cell leukaemia. Bone Marrow Transplant 2010; 45: 1117-1118.
31. Imamura T, Ohtsuka E, Ogata M, Oka F, Kashima K, Kikuchi H, Nasu M: Successful induction of long-term remission using rituximab in a patient with refractory hairy cell leukemia-Japanese variant. Int J Hematol 2004; 80: 432-434. (Pubitemid 40053625)
32. Quach H, Januszewicz H, Westerman D: Complete remission of hairy cell leukemia variant (HCL-v) complicated by red cell aplasia post treatment with rituximab. Haematologica 2005; 90:ECR26.
33. Sasaki M, Sugimoto K, Mori T, Karasawa K, Oshimi K: Effective treatment of a refractory hairy cell leukemia variant with splenic preirradiation and alemtuzumab. Acta Haematol 2008; 119: 48-53. (Pubitemid 351363859)
34. Kreitman RJ, Wilson WH, Bergeron K, Raggio M, Stetler-Stevenson M, FitzGerald DJ, Pastan I: Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapyresistant hairy-cell leukemia. N Engl J Med 2001; 345: 241-247. (Pubitemid 32695063)